Leave Your Message

Probiotics are closely related to metabolism

2025-01-07

Probiotics are intricately connected to metabolic processes within the human body. It is important to note that our intestines are not devoid of life; rather, they are populated by a diverse community of microorganisms, primarily bacteria, which constitute approximately 78% of the total microbial biomass present in the human body. Collectively, these microorganisms are referred to as the gut microbiota.

 

Contemporary medical research underscores the significance of the gut microbiota in facilitating a multitude of complex physiological functions. These functions encompass the regulation of the endocrine hormones, modulation of immune responses, and the conversion of various metabolic products. Additionally, the gut microbiota is closely associated with the functional regulation of vital organs, including the liver, kidneys, and even the brain, highlighting its systemic influence on overall health.

 

Research conducted as early as 2015 by Patrice D. revealed that dysbiosis, or an imbalance in the gut microbiota, is a significant factor contributing to the onset of metabolic syndrome. More recently, a study published in Nature in 2023, which involved about 306 participants, demonstrated that the gut bacteria play a pivotal role in carbohydrate metabolism, with implications for insulin resistance.

 

In a related vein, a recent investigation published in Cell has uncovered that the gut microbiota facilitates host uric acid homeostasis through mechanisms that were previously unrecognized. This discovery may pave the way for novel therapeutic strategies targeting hyperuricemia and gout. Hyperuricemia, along with insulin resistance and complications associated with glucose metabolism and obesity, are all manifestations of metabolic syndrome. The intricate relationship between the gut microbiota and these conditions further reinforces the hypothesis that dysbiosis is a contributing factor to the development of metabolic syndrome.

 

Consequently, the endogenous regulation of metabolic disorders through the administration of the probiotics emerges as an essential and irreplaceable strategy in the management of these conditions.

Bioyitech's metabolic management solutions

Bioyitech's metabolic management solutions are strategically designed to address four critical areas: carbohydrate and lipid metabolism, uric acid intervention, weight management, and liver health. These solutions are meticulously tailored to meet the extensive and profound societal needs, particularly focusing on the unique physical characteristics of the Chinese population. Bioyitech has dedicated over eight years to researching core functional strains, establishing a robust foundation for its innovative approaches.

1. **Glycolipid Metabolism - 15-30 Day Protocol**

1

Research conducted by Zhongchuang Laboratory has demonstrated that the Bioyitech 15-30 glycemic reduction protocol can significantly lower blood glucose and lipid levels within a mere 15 days, provided the recommended dosage is adhered to. This protocol effectively addresses issues related to insufficient insulin secretion, insulin resistance, and insulin insensitivity. Furthermore, it enhances lipid metabolism and optimizes cholesterol structure within a 30-day timeframe, promoting overall metabolic health.

2. **Uric Acid Intervention - 30-60 Day Protocol**

2

The Bioyitech 30-60 uric acid intervention solution, substantiated by effective population studies, is capable of restoring uric acid metabolic homeostasis within a 30-60 day period. This intervention not only alleviates gout symptoms but also aids in the repair of long-term kidney damage caused by the accumulation of uric acid crystal salts, thereby improving renal function and overall health.

3. **Liver Care - 2-90 Day Protocol**

3

The Bioyitech 2-90 liver care protocol, validated through comprehensive population studies, is designed to mitigate hangover symptoms following alcohol consumption and reduce alcohol-related bodily damage when followed as recommended. Over a 90-day period, this protocol effectively addresses both alcohol-induced and non-alcohol-induced liver damage. The degree of improvement can be monitored through biochemical indicators such as HDL, LDL, TG, TC, ALT, and AST, which provide insights into the reduction of liver fat and inflammation.

4. **Body Management - 30-90 Day Protocol**

4

 

Bioyitech's 30-90 body management protocol is centered around the patented Probiotic Strain F3-2, often referred to as the "Orlistat of probiotics," which effectively inhibits lipid absorption. Population studies have shown that this protocol can lead to a reduction in waist circumference and BMI over a 30-90 day period, achieving a "dual reduction" in both body fat and visceral fat. This comprehensive approach supports long-term body management and promotes overall health and wellness.